Matthew W. Foehr
2019 - Ligand Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $195,000 |
|---|---|
| Option Awards | $1,686,480 |
| Salary | $487,500 |
| Stock Awards | $1,711,163 |
| Other | $164,766 |
| Total | $4,244,909 |
Foehr received $1.7M in stock awards, accounting for 40% of the total pay in 2019.
Foehr also received $195K in non-equity incentive plan, $1.7M in option awards, $487.5K in salary and $164.8K in other compensation.
Rankings
In 2019, Matthew W. Foehr's compensation ranked 2,771st out of 13,971 executives tracked by ExecPay. In other words, Foehr earned more than 80.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,771 out of 13,971 | 80th |
Division Manufacturing | 998 out of 5,695 | 83rd |
Major group Chemicals And Allied Products | 331 out of 2,194 | 85th |
Industry group Drugs | 269 out of 1,880 | 86th |
Industry Pharmaceutical Preparations | 199 out of 1,392 | 86th |
Pay ratio
| Matthew W. Foehr's Pay | $4,244,909 |
|---|---|
| Median Employee's Pay | $109,795 |
| Pay Ratio | 39to 1 |
In 2019, the annual total compensation of Matthew W. Foehr was $4,244,909.
The annual total compensation of the median employee at Ligand Pharmaceuticals was $109,795.
The ratio of Matthew W. Foehr's pay to the pay of median employee was therefore 39 to one.
Foehr's colleagues
We found three more compensation records of executives who worked with Matthew W. Foehr at Ligand Pharmaceuticals in 2019.